NSE BSE
kerala ayurveda ltd. stock

KERALA AYURVEDA LTD. Share Price

- - (%)
- NSE: KERALAYUR

KERALA AYURVEDA LTD. Share Price Update

As of the latest trading session, KERALA AYURVEDA LTD. share price is currently at 339.55, which is down by -17.85 from its previous closing. Today, the stock has fluctuated between 339.55 and 355.75. Over the past year, KERALA AYURVEDA LTD. has achieved a return of 241.84 %. In the last month alone, the return has been 23.60 %. Read More...

KERALA AYURVEDA LTD. Performance

Day Range

Low339.55 High355.75
339.55

52 Week Range

Low 104.55 High 417.00
339.55

KERALA AYURVEDA LTD. Share Price

530163

KERALAYUR

img img img img
No Data Available

Open Price

345.25

Prev. Close

357.40

Volume (Shares)

19545.00

Total traded value

67.05

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

KERALA AYURVEDA LTD. Fundamentals


(Standalone)

Market Cap (Cr) 358.41
PE Ratio (TTM) 0.00
Book Value / Share 35.21
Beta 0.62
ROE 2.03%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -0.72

KERALA AYURVEDA LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 17.05
Operating Expense 17.15
Net Profit -0.72
Net Profit Margin (%) -4.22
Earnings Per Share (EPS) 0.81
EBITDA 1.30
Effective Tax Rate (%) -77.49
Particulars DEC 2023 (Values in Cr)
Revenue 17.28
Operating Expense 17.49
Net Profit -0.27
Net Profit Margin (%) -1.56
Earnings Per Share (EPS) -0.18
EBITDA 0.54
Effective Tax Rate (%) -107.69
Particulars SEP 2023 (Values in Cr)
Revenue 18.75
Operating Expense 18.81
Net Profit 0.51
Net Profit Margin (%) 2.72
Earnings Per Share (EPS) 1.05
EBITDA 1.31
Effective Tax Rate (%) 25.00
Particulars JUN 2023 (Values in Cr)
Revenue 17.00
Operating Expense 16.79
Net Profit 0.21
Net Profit Margin (%) 1.23
Earnings Per Share (EPS) 0.26
EBITDA 1.85
Effective Tax Rate (%) 25.92
Particulars MAR 2023 (Values in Cr)
Revenue 15.09
Operating Expense 15.71
Net Profit 0.67
Net Profit Margin (%) 4.44
Earnings Per Share (EPS) 2.00
EBITDA 0.67
Effective Tax Rate (%) 211.66
Particulars MAR 2024 (Values in Cr)
Revenue 67.62
Operating Expense 67.78
Net Profit -0.27
Net Profit Margin (%) -0.39
Earnings Per Share (EPS) -0.25
EBITDA 5.02
Effective Tax Rate (%) 162.79
Particulars MAR 2023 (Values in Cr)
Revenue 59.12
Operating Expense 59.64
Net Profit 2.89
Net Profit Margin (%) 4.88
Earnings Per Share (EPS) 3.09
EBITDA 7.45
Effective Tax Rate (%) -21.94
Particulars MAR 2022 (Values in Cr)
Revenue 51.72
Operating Expense 50.79
Net Profit 0.89
Net Profit Margin (%) 1.72
Earnings Per Share (EPS) 1.17
EBITDA 7.88
Effective Tax Rate (%) 28.45
Particulars MAR 2021 (Values in Cr)
Revenue 40.10
Operating Expense 46.84
Net Profit -4.95
Net Profit Margin (%) -12.34
Earnings Per Share (EPS) -4.38
EBITDA 0.28
Effective Tax Rate (%) 24.77
Particulars MAR 2020 (Values in Cr)
Revenue 50.08
Operating Expense 49.01
Net Profit 0.88
Net Profit Margin (%) 1.75
Earnings Per Share (EPS) 1.12
EBITDA 3.12
Effective Tax Rate (%) 27.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share 5.28
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 12.18
EBITDA Margin 3.11
Particulars MAR 2022 (Values in Cr)
Book Value / Share 5.79
ROE % 13.28
ROCE % 9.31
Total Debt to Total Equity 15.40
EBITDA Margin 12.30
Particulars MAR 2021 (Values in Cr)
Book Value / Share 3.22
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 12.42
EBITDA Margin 1.53
Particulars MAR 2020 (Values in Cr)
Book Value / Share 7.51
ROE % 17.88
ROCE % 6.60
Total Debt to Total Equity 10.80
EBITDA Margin 9.61
Particulars MAR 2019 (Values in Cr)
Book Value / Share 3.53
ROE % 6.36
ROCE % 4.50
Total Debt to Total Equity 11.76
EBITDA Margin 8.64
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.77
ROE % 2.03
ROCE % 4.88
Total Debt to Total Equity 4.80
EBITDA Margin 7.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 10.68
ROE % 5.44
ROCE % 8.40
Total Debt to Total Equity 5.97
EBITDA Margin 14.39
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.51
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 5.01
EBITDA Margin 0.88
Particulars MAR 2020 (Values in Cr)
Book Value / Share 13.90
ROE % 3.89
ROCE % 2.94
Total Debt to Total Equity 4.05
EBITDA Margin 6.07
Particulars MAR 2019 (Values in Cr)
Book Value / Share 12.78
ROE % 0.79
ROCE % 2.95
Total Debt to Total Equity 4.04
EBITDA Margin 7.01
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.19
Total Assets 114.71
Total Liabilities 114.71
Total Equity 7.88
Share Outstanding 10555670
Price to Book Ratio 6.06
Return on Assets (%) -0.78
Return on Capital (%) -1.12
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 2.87
Total Assets 110.31
Total Liabilities 110.31
Total Equity 7.94
Share Outstanding 10555670
Price to Book Ratio 7.32
Return on Assets (%) 2.14
Return on Capital (%) 3.03
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 18.55
Total Assets 114.48
Total Liabilities 114.48
Total Equity 5.20
Share Outstanding 10555670
Price to Book Ratio 5.40
Return on Assets (%) -4.23
Return on Capital (%) -5.91
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 6.36
Total Assets 102.96
Total Liabilities 102.96
Total Equity 9.72
Share Outstanding 10555670
Price to Book Ratio 2.63
Return on Assets (%) 3.78
Return on Capital (%) 5.27
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 4.55
Total Assets 92.29
Total Liabilities 92.29
Total Equity 5.37
Share Outstanding 10555670
Price to Book Ratio 5.23
Return on Assets (%) 2.64
Return on Capital (%) 3.64
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.54
Total Assets 97.52
Total Liabilities 97.52
Total Equity 14.53
Share Outstanding 10555670
Price to Book Ratio 6.06
Return on Assets (%) 2.96
Return on Capital (%) 3.75
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 91.69
Total Liabilities 91.69
Total Equity 11.27
Share Outstanding 10555670
Price to Book Ratio 7.32
Return on Assets (%) 0.97
Return on Capital (%) 1.22
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.07
Total Assets 96.22
Total Liabilities 96.22
Total Equity 10.04
Share Outstanding 10555670
Price to Book Ratio 5.40
Return on Assets (%) -5.14
Return on Capital (%) -6.51
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.90
Total Assets 93.60
Total Liabilities 93.60
Total Equity 14.66
Share Outstanding 10555670
Price to Book Ratio 2.63
Return on Assets (%) 0.93
Return on Capital (%) 1.21
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.84
Total Assets 87.15
Total Liabilities 87.15
Total Equity 13.49
Share Outstanding 10555670
Price to Book Ratio 5.23
Return on Assets (%) 1.37
Return on Capital (%) 1.72
Particulars MAR 2023 (Values in Cr)
Net Income 4.26
Cash from Operations 10.22
Cash from Investing -7.21
Cash from Financing -2.31
Net change in Cash 0.32
Free Cash Flow 16.41
Particulars MAR 2022 (Values in Cr)
Net Income 9.32
Cash from Operations -0.50
Cash from Investing -1.90
Cash from Financing -13.27
Net change in Cash -15.68
Free Cash Flow 2.34
Particulars MAR 2021 (Values in Cr)
Net Income -0.41
Cash from Operations 7.42
Cash from Investing -1.43
Cash from Financing 6.20
Net change in Cash 12.19
Free Cash Flow 8.46
Particulars MAR 2020 (Values in Cr)
Net Income 6.08
Cash from Operations 5.20
Cash from Investing -4.02
Cash from Financing 0.84
Net change in Cash 1.81
Free Cash Flow 8.54
Particulars MAR 2019 (Values in Cr)
Net Income 5.52
Cash from Operations 13.05
Cash from Investing -2.90
Cash from Financing -11.55
Net change in Cash -2.16
Free Cash Flow 15.51
Particulars MAR 2023 (Values in Cr)
Net Income 6.81
Cash from Operations 9.11
Cash from Investing -5.32
Cash from Financing -3.38
Net change in Cash 0.41
Free Cash Flow 10.05
Particulars MAR 2022 (Values in Cr)
Net Income 7.12
Cash from Operations 8.75
Cash from Investing 0.82
Cash from Financing -10.51
Net change in Cash -0.94
Free Cash Flow 11.05
Particulars MAR 2021 (Values in Cr)
Net Income -0.52
Cash from Operations -0.91
Cash from Investing -2.10
Cash from Financing 2.18
Net change in Cash -0.83
Free Cash Flow 0.03
Particulars MAR 2020 (Values in Cr)
Net Income 2.43
Cash from Operations 4.70
Cash from Investing -3.93
Cash from Financing 0.28
Net change in Cash 1.06
Free Cash Flow 7.46
Particulars MAR 2019 (Values in Cr)
Net Income 3.83
Cash from Operations 9.97
Cash from Investing -1.69
Cash from Financing -11.14
Net change in Cash -3.50
Free Cash Flow 11.96
Company Name Price P/E P/B Market Cap 52 Week Low/High
KERALA AYURVEDA LTD. 357.40 0.00 13.37 430.04 104.55 / 417.00
BLISS GVS PHARMA LTD 116.40 12.72 1.26 1219.15 77.65 / 148.95
CIPLA LTD 1505.80 28.56 4.55 121596.06 1018.30 / 1581.70
FERMENTA BIOTECH LIMITED 203.65 0.00 2.07 599.36 136.00 / 219.05
GLAXOSMITHKLINE PHARMA LT 2559.65 66.04 24.39 43362.02 1376.50 / 2759.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
KERALA AYURVEDA LTD. 357.40 0.00 10.14 430.04 104.55 / 417.00
AMRUTAJAN HEALTH LTD 761.05 48.91 7.62 2200.24 556.05 / 826.00
ASTRAZENECA PHARMA IND LT 6864.45 114.79 24.10 17161.13 3650.05 / 7550.00
BLISS GVS PHARMA LTD 116.40 16.01 1.23 1219.15 77.65 / 148.95
ABBOTT INDIA LIMITED 27823.05 49.22 15.98 59123.98 21907.45 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 380.30
  • 26 Days 337.50
  • 10 Days 366.40
  • 50 Days 324.80
  • 12 Days 363.00
  • 100 Days 303.90
  • 20 Days 348.70
  • 200 Days 150.80
361.27
PIVOT
First Resistance 365.13
Second Resistance 372.87
Third Resistance 376.73
First Support 353.53
Second Support 349.67
Third Support 341.93
RSI 61.04
MACD 25.51
Commodity Channel Index (CCI) 46.14
ADX 38.87
Williams % R -53.24

Over 1 Month

down

23.60

Over 3 Months

down

37.64

Over 6 Months

down

19.49

Over 1 Year

down

241.84

Over 3 Years

down

81.72

Over 5 Years

down

43.12

KERALA AYURVEDA LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

KERALA AYURVEDA LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
41.39
Promoter Holdings
58.57
FII
0.0
DII
0.02
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Katra Holdings Ltd Shareholding of Promoter and Promoter Group 6493435.0 53.97
Porinju Veliyath Public Shareholding 623000.0 5.18
Katra Phytochem India Private Limited Shareholding of Promoter and Promoter Group 555000.0 4.61
Sanjiv Dhireshbhai Shah Public Shareholding 347826.0 2.89
Dheeraj Kumar Lohia Public Shareholding 244094.0 2.03
Anilkumar K Public Shareholding 193005.0 1.6
Sashikanth Balachandar Public Shareholding 152030.0 1.26

KERALA AYURVEDA LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About KERALA AYURVEDA LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by KERALA AYURVEDA LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Kerala Ayurveda Ltd?

Answer Field

The share price of Kerala Ayurveda Ltd for NSE is ₹ 0.00 and for BSE is ₹ 339.55.

What is the Market Cap of Kerala Ayurveda Ltd?

Answer Field

The market cap of Kerala Ayurveda Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 408.60 Cr. as of now.

What is the 52 Week High and Low of Kerala Ayurveda Ltd?

Answer Field

The 52 Week High and Low of Kerala Ayurveda Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 417.00 and ₹ 104.55.

How to Buy Kerala Ayurveda Ltd share?

Answer Field

You can trade in Kerala Ayurveda Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Kerala Ayurveda Ltd?

Answer Field

The 1 year returns on the stock has been 241.84%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader